A Class III implantable device for patent foramen ovale closure using biodegradable materials that naturally resorb after tissue integration. This system represents China's first degradable PFO closure product approved through expedited regulatory pathway.
Manufactured by
Beijing Healtech Pharmaceutical Technology Co.,Ltd
China
Healtech Group, founded in 2006, provides integrated CRO and CDMO services for the biopharmaceutical industry. Services include R&D, product testing, animal studies, clinical trials, and regulatory registration to support market authorization of pharmaceutical and medical products.
© 2026 Suplivia · Home · Browse Products